AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.5200
-0.0060 (-1.14%)
At close: Apr 23, 2026, 4:00 PM EDT
0.5200
0.00 (0.00%)
After-hours: Apr 23, 2026, 6:30 PM EDT
AIM ImmunoTech Stock Forecast
AIM's stock price has decreased by -85.54% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for AIM ImmunoTech stock has a target of 10, which predicts a 1,823.08% increase from the current stock price of 0.52.
Price Target: $10 (+1,823.08%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for AIM ImmunoTech is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $22 → $10 | Strong Buy | Maintains | $22 → $10 | +1,823.08% | Apr 10, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $24 → $22 | Strong Buy | Maintains | $24 → $22 | +4,126.92% | Dec 8, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $150 → $24 | Strong Buy | Maintains | $150 → $24 | +4,511.54% | Oct 3, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5 → $4.5 | Strong Buy | Maintains | $5 → $4.5 | +765.38% | Dec 10, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $2 → $1 | Strong Buy | Maintains | $2 → $1 | +92.31% | Oct 22, 2024 |
Financial Forecast
Revenue This Year
101.00K
from 88.00K
Increased by 14.77%
Revenue Next Year
9.85M
from 101.00K
Increased by 9,650.50%
EPS This Year
-3.32
from -8.62
EPS Next Year
-1.62
from -3.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 105,000 | 10.2M | |||
| Avg | 101,000 | 9.8M | |||
| Low | 98,000 | 9.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.3% | 10,036.6% | |||
| Avg | 14.8% | 9,650.5% | |||
| Low | 11.4% | 9,360.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.37 | -1.69 | |
| Avg | -3.32 | -1.62 | |
| Low | -4.24 | -1.58 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.